The pathogenesis of beta(2)-microglobulin-induced bone lesions in dialysis-related amyloidosis

M Tran1, G W Rutecki, S M Sprague

  • 1Department of Medicine, Division of Nephrology, Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA.

Seminars in Dialysis
|March 27, 2001
PubMed

Insights

Dialysis-related amyloidosis (DRA), caused by beta(2)-microglobulin (Aβ2M) deposition, leads to significant morbidity in dialysis patients. Further research is needed to understand the complex mechanisms linking Aβ2M accumulation to bone and joint destruction.

Area of Science:

  • Nephrology
  • Rheumatology
  • Biochemistry

Background:

  • Dialysis-related amyloidosis (DRA), or beta(2)-microglobulin amyloidosis (Aβ2M), is a major complication in chronic renal failure patients undergoing dialysis.
  • While the amyloid fibril protein in DRA is identified as beta(2)-microglobulin (β2M), its specific role in bone and joint pathology remains unclear.

Purpose of the Study:

  • To explore the pathological mechanisms by which β2M contributes to bone and joint disease in the context of DRA.
  • To investigate potential interactions between β2M and factors like growth factors, cytokines, and advanced glycation end products (AGEs) in bone.

Main Methods:

  • Characterization of DRA deposits in affected joints.
  • Review of potential molecular mechanisms involved in β2M's interaction with bone tissue.

Main Results:

  • DRA is characterized by the deposition of β2M amyloid fibrils.
  • Potential pathways for β2M's pathological role in bone involve growth factors, cytokines, and AGEs.

Conclusions:

  • DRA results from a complex interplay of bone resorption and tissue damage, leading to β2M deposition and amyloid formation.
  • Further investigation is required to fully elucidate the relationship between β2M accumulation and progressive tissue destruction in DRA.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...